Longbow Immunotherapy

Longbow Immunotherapy is a preclinical CAR-T company focused on applications for solid tumors. Longbow also plans to expand the application of ReACT beyond bladder cancer, as ReACT T cells can be engineered to recognize and synergize with any bacterial immunotherapy or oncolytic virus targeting solid tumors.